Match each clinical intervention (left) with the underlying pharmacokinetic or pharmacodyn… — USMLE Step 3

Match each clinical intervention (left) with the underlying pharmacokinetic or pharmacodynamic mechanism (right) responsible for the resulting drug interaction or therapeutic effect.

Intravenous buprenorphine administered to a patient currently experiencing analgesia from high-dose methadoneHigh-affinity competitive receptor binding resulting in a decreased maximal pharmacodynamic response ( $E_{max}$ )
Initiation of oral rifampin therapy in a patient stabilized on a combined oral contraceptive pillIncreased hepatic clearance ( $CL$ ) and decreased steady-state plasma concentration ( $C_{ss}$ ) via enzyme induction
Intravenous administration of protamine sulfate to a patient with severe bleeding following an unfractionated heparin infusionDirect chemical antagonism via electrostatic interaction, independent of cellular receptors
Addition of oral probenecid to intravenous cefazolin therapy in a patient being treated for severe osteomyelitisDecreased clearance ( $CL$ ) and increased half-life ( $t_{1/2}$ ) due to competition for renal organic anion transporters
Oral cholestyramine taken simultaneously with oral levothyroxineDecreased systemic bioavailability ( $F$ ) due to intraluminal sequestration in the gastrointestinal tract

Cevap

The correct matches align specific drug interventions with their precise pharmacokinetic (absorption, metabolism, excretion) or pharmacodynamic (receptor activity, chemical neutralization) mechanisms.

Each correct pairing accurately maps a well-known clinical scenario to its foundational pharmacokinetic or pharmacodynamic mechanism. Recognizing whether an interaction occurs during absorption (

F

), metabolism (

CL

), excretion (

CL

), at the receptor (

E_{max}

), or via direct chemical means is essential for safe patient management.

Adım Adım Çözüm

Analyze the buprenorphine and methadone interaction.

Matches to high-affinity competitive binding and decreased

E_{max}

Buprenorphine (partial agonist) displaces methadone (full agonist) at the mu-opioid receptor, capping the maximal therapeutic effect.

Analyze the rifampin and oral contraceptive interaction.

Matches to increased hepatic clearance (

CL

) and decreased

C_{ss}

Rifampin induces CYP3A4, causing rapid metabolism of the oral contraceptive hormones.

Analyze the protamine and heparin interaction.

Matches to direct chemical antagonism via electrostatic interaction.

Protamine (positive) binds directly to heparin (negative) in the blood, representing chemical antagonism independent of biologic receptors.

Analyze the probenecid and cefazolin interaction.

Matches to decreased clearance (

CL

) and increased

t_{1/2}

via OAT competition.

Probenecid blocks renal active tubular secretion of beta-lactams, deliberately prolonging their therapeutic levels.

Analyze the cholestyramine and levothyroxine interaction.

Matches to decreased systemic bioavailability (

F

) due to intraluminal sequestration.

Resins directly bind drugs in the GI tract, preventing them from being absorbed into the systemic circulation.

Anahtar Kavram

Various mechanisms of drug-drug interactions including pharmacodynamic receptor competition, chemical antagonism, pharmacokinetic induction of metabolism, inhibition of renal secretion, and alteration of gastrointestinal absorption.

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru